Back to BARCLAYS PLC BARCLAYS PLC

KNTEKNTE
9 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in KINNATE BIOPHARMA INC

BARCLAYS PLC previously held 0 shares of KNTE (KINNATE BIOPHARMA INC), worth $0 as of 2024-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$197,000

Total Shares Change

-15,652

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%
0
2024-Q1
Decreased
14,185
-2.6%
$37,7320.0%
0
2023-Q4
Unchanged
14,568
0.0%
$34,5260.0%
0
2023-Q3
Unchanged
14,568
0.0%
$20,3950.0%
0
2023-Q2
Decreased
14,568
-50.5%
$44,1410.0%
0
2023-Q1
Increased
29,425
+20.7%
$183,9070.0%
27
2022-Q4
Increased
24,386
+58.1%
$148,7550.0%
32
2022-Q3
Decreased
15,424
-1.5%
$185,0000.0%
0
2022-Q2
New
15,652
-
$197,0000.0%
32

Other major holders of KNTE: RA CAPITAL MANAGEMENT, L.P., VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used